Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Pilot study to evaluate the management of curative anticoagulant prescriptions pre- and postoperatively in elderly patients hospitalized for femoral neck fracture.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Rate of compliance with the recommendations for direct oral anticoagulants (DOAC).. | Rate of compliance with the french working group on perioperative haemostasis (GIHP) recommendations for DOACrecommendations for DOA. | Day 0 |
| Rate of compliance with the recommendations for vitamin K antagonists (VKA). | Rate of compliance with the french health authority (HAS) recommendations for VKA | Day 0 |
| Measure | Description | Time Frame |
|---|---|---|
| Number of pharmaceutical interventions | Number of pharmaceutical interventions regarding anticoagulant prescriptions | Day 0 |
| description of pharmaceutical interventions | description of pharmaceutical interventions |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients aged 75 years and older, hospitalized in the geriatric perioperative unit from November 18, 2019 to June 30, 2021, for a hip fracture and with curative anticoagulant therapy prescription at entry.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chu Nimes | Nîmes | 30029 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Day 0 |
| Evaluation of the morbi-mortality | Mortality, re-hospitalizations at 30 days, characterization of bleeding complications, characterization of thrombotic complications | Day 0 |
| Description of the evolution of the plasma dosage of DOAC and the international normalized ratio (INR) and analysis of the operative delay | Value of preoperative DOAC plasma dosage, value of INR dosage pre- and post-op, analysis of the operative delay | Day 0 |
| description of the population | age, weight, height, body mass index, comorbidities | Day 0 |
| ID | Term |
|---|---|
| D006474 | Hemorrhagic Disorders |
| D005265 | Femoral Neck Fractures |
| ID | Term |
|---|---|
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D006620 | Hip Fractures |
| D005264 | Femoral Fractures |
| D050723 | Fractures, Bone |
| D014947 | Wounds and Injuries |
| D025981 | Hip Injuries |
| D007869 | Leg Injuries |
Not provided
Not provided